The Oocyte Quality in Ovarian Endometriosis

The Oocyte Quality in Ovarian Endometriosis By Selma Oransay

Endometrioma is the ovarian involvement of endometriosis affecting up to 44% of women diagnosed with the disease. Owing to the anatomical locus, ovarian endometriosis may impair folliculogenesis and oocyte competence, differing from other forms of endometriosis.  When investigating the relationship between…

Key Points Lay Summary

Endometriosis Seems to Affect The Development of the Embryo

Endometriosis Seems to Affect The Development of the Embryo By Özge Özkaya

Embryos development is impaired in embryos from women with endometriosis found a new study published in the Journal of Assisted Reproduction and Genetics. In spite of this, the outcomes of in vitro fertilization (IVF) are similar for patients with endometriosis…

Key Points Lay Summary

Impact of Endometriosis on Embryo Development

Impact of Endometriosis on Embryo Development By Dr. Youngran Park

Endometriosis is a hormone-dependent disorder which affects approximately 10% of women in reproductive age. There are many endometriosis-related problems, but infertility is one of the well-known issues which should be handled and understood. Despite numerous trials, the mechanisms and pathology…

Key Points Lay Summary

The use of Elagolix in Women with Liver and Kidney Impairments

The use of Elagolix in Women with Liver and Kidney Impairments By Özge Özkaya

Elagolix may be used in women with moderate liver impairment, when necessary, for up to six months at a dose of 150 mg a day, according to a study published in the scientific journal Clinical Pharmacology in Drug Development. The…

Key Points Lay Summary

A Potential New Drug for Endometriosis?

A Potential New Drug for Endometriosis?  By Özge Özkaya

A steroid derivative called PBRM could be a new emerging drug to treat endometriosis according to a study by Canadian scientists. In the study that was published in The Journal of Steroid Biochemistry and Molecular Biology, researchers characterized the pharmaceutical…

Key Points Lay Summary